Stockscreener 앱 받기
6.41
0.63%
0.04
Nutriband Inc 주식(NTRB)의 최신 뉴스
Nutriband (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting Milestones, Commercialization Goals - Barchart.com
Examining Nutriband Inc (NTRB) more closely is necessary - uspostnews.com
A Tale of Resilience: Nutriband Inc Amid Stock Market Turbulence - investchronicle.com
Nutriband CEO Publishes Letter to Shareholders - GlobeNewswire
Nutriband (NASDAQ: NTRB) Leadership Team: Driving Innovation and Shaping the Future of Global Healthcare - The Globe and Mail
Nutriband (NTRB) Highlights Key Milestones and Future Goals Amid - GuruFocus
Nutriband Inc. (NASDAQ: NTRB) Solution To Fentanyl Abuse Could Translate To $200 Million In Peak Revenue - marketscreener.com
Nutriband CEO Publishes Letter to Shareholders | NTRB Stock News - GuruFocus
Nutriband projects strong sales for abuse-deterrent patches - Investing.com Australia
ForexTV | Small Business Resources - ForexTV
Nutriband's Revolutionary Abuse-Deterrent Patch Eyes $200M Market: CEO Details Growth Strategy - Stock Titan
Nutriband Full Year 2025 Earnings: Misses Expectations - Yahoo Finance
Nutriband Inc. Leadership Gains International Recognition for Entrepreneurial Excellence - citybuzz -
Nutriband Inc reports results for the quarter ended January 31Earnings Summary - TradingView
NutriBand Inc. SEC 10-K Report - TradingView
Press Release Distribution & PR Platform - ACCESS Newswire
Should You Buy, Sell or Hold Amazon Stock Before Q1 Earnings? - The Globe and Mail
Why Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Big Oil Could Trim Buybacks After Price Rout - The Globe and Mail
Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services - ACCESS Newswire
Is Disney Stock a Buy Now as Trump Tones Down Trade War Rhetoric? - The Globe and Mail
Nutriband (NASDAQ: NTRB): Building A Moat Around Abuse-Deterrent Drug Delivery - Barchart.com
(NTRB) Investment Report - news.stocktradersdaily.com
Nutriband (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery - The Globe and Mail
Nutriband Strengthens Intellectual Property Portfolio for Abuse-Deterrent Drug Delivery - citybuzz -
Stocks in play: BioVaxys Technology Corp - The Globe and Mail
Nutriband (NASDAQ: NTRB) CEO Named EY Entrepreneur of the Year 2025 Finalist - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One to Watch’ - The Globe and Mail
Nutriband (NASDAQ: NTRB) Is ‘One To Watch’ - Barchart.com
Nutriband Advances Opioid Safety with Innovative AVERSA Technology - citybuzz -
Nutriband (NTRB) Achieves Key Patent Approval in Macao for AVERS - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology | NTRB Stock News - GuruFocus
Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology - GlobeNewswire
Nutriband secures Macao patent for drug abuse deterrent tech By Investing.com - Investing.com South Africa
Nutriband Receives Patent for Abuse, Misuse Deterrent Transdermal Systems in Macao - marketscreener.com
Nutriband secures Macao patent for drug abuse deterrent tech - Investing.com
Revolutionary Opioid Safety Tech: Nutriband Secures 46-Country Patent Protection - Stock Titan
Nutriband Partners with Charlotte FC for Brand Visibility - TipRanks
Nutriband (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand Visibility - The Globe and Mail
(NTRB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M - ACCESS Newswire
UPDATENutriband Signs Associate Partnership with Charlotte FC - The Manila Times
UPDATE – Nutriband Signs Associate Partnership with Charlotte FC - Bluefield Daily Telegraph
0.39%
3.66%
자본화:
|
볼륨(24시간):